{"disease":{"id":"rosacea","name":"Rosacea","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":21,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"fusidic-acid","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"doxycyclin","indication_name":"Severe Recalcitrant Nodular Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxycyclin","company_name":"Bulovka Hospital","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"brimonidine-tartrate","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alphagan","generic_name":"BRIMONIDINE TARTRATE","company_name":"Senju Pharmaceutical Co., Ltd","drug_phase":"marketed","molecular_target":"Alpha-2C adrenergic receptor","drug_class":"alpha-Adrenergic Agonist","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"azelaic-acid","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azelex","generic_name":"AZELAIC ACID","company_name":"Leo Pharma As","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 2","drug_class":"azelaic acid","quality_score":51,"revenue":null,"mechanism":"Azelex works by inhibiting the enzyme 3-oxo-5-alpha-steroid 4-dehydrogenase 2, which is involved in the production of androgens that contribute to acne and rosacea."},{"drug_id":"loteprednol-etabonate","indication_name":"Ocular rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotemax","generic_name":"LOTEPREDNOL ETABONATE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"loteprednol-etabonate","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotemax","generic_name":"LOTEPREDNOL ETABONATE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tobramycin","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tobi","generic_name":"tobramycin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"fluorometholone","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fml","generic_name":"FLUOROMETHOLONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"brimonidine","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alphagan","generic_name":"BRIMONIDINE","company_name":"Senju Pharmaceutical Co., Ltd","drug_phase":"marketed","molecular_target":"Alpha-2C adrenergic receptor","drug_class":"alpha-Adrenergic Agonist","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"medrysone","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrifar","generic_name":"MEDRYSONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"metronidazole","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metro I.V. In Plastic Container","generic_name":"METRONIDAZOLE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"","drug_class":"Nitroimidazole Antimicrobial [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"lotemax","indication_name":"Ocular rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lotemax","company_name":"Tufts Medical Center","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lotemax","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lotemax","company_name":"Tufts Medical Center","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"dexamethasone","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"tobramycin-sulfate","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vantobra","generic_name":"Tobramycin Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20","drug_class":"tobramycin","quality_score":68,"revenue":null,"mechanism":""},{"drug_id":"nebcin","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Nebcin","company_name":"University Hospital, Lille","drug_phase":"discontinued","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"finacea","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Finacea","company_name":"Actavis Inc.","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 2","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"hydrocortisone","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fluorometholone-acetate","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flarex","generic_name":"FLUOROMETHOLONE ACETATE","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"loteprednol","indication_name":"acne rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loteprednol Etabonate","generic_name":"LOTEPREDNOL","company_name":"Bausch And Lomb","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"doxycycline","indication_name":"Severe Recalcitrant Nodular Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Ocular rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolone","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Ocular rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"metronidazol","indication_name":"Rosacea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metronidazol","company_name":"University of Oslo","drug_phase":"marketed","molecular_target":"Thioredoxin reductase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"pf-07038124","indication_name":"Papulopustular Rosacea","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07038124","generic_name":"pf-07038124","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Phosphodiesterase-4 (PDE4)","drug_class":"Phosphodiesterase-4 inhibitor","quality_score":25,"revenue":null,"mechanism":"PF-07038124 is a topical PDE4 inhibitor that blocks phosphodiesterase-4 to reduce inflammatory cytokine production in skin immune cells."}],"offLabel":[],"totalMarketed":28,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03193372","title":"A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea","phase":"","overall_status":"COMPLETED","enrollment_count":2200,"lead_sponsor_name":"LEO Pharma","has_results":false},{"nct_id":"NCT03689010","title":"To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1116,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03954444","title":"A Clinical Endpoint Bioequivalence Study of \"Oxymetazoline Hydrochloride Cream\"","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1105,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT03094403","title":"To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT05928169","title":"Determinants of Chronic Inflammatory Skin Disease Trajectories","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false},{"nct_id":"NCT03287791","title":"A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":924,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT04608500","title":"A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":771,"lead_sponsor_name":"Vyne Therapeutics Inc.","has_results":true},{"nct_id":"NCT03142451","title":"A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":751,"lead_sponsor_name":"Vyne Therapeutics Inc.","has_results":true},{"nct_id":"NCT03872050","title":"Deep Phenotyping of Rosacea and Migraine","phase":"","overall_status":"COMPLETED","enrollment_count":613,"lead_sponsor_name":"Danish Headache Center","has_results":false},{"nct_id":"NCT03564145","title":"A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":547,"lead_sponsor_name":"Sol-Gel Technologies, Ltd.","has_results":true},{"nct_id":"NCT04106726","title":"Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":525,"lead_sponsor_name":"Zydus Worldwide DMCC","has_results":false},{"nct_id":"NCT03276936","title":"A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":504,"lead_sponsor_name":"Vyne Therapeutics Inc.","has_results":true},{"nct_id":"NCT06466018","title":"Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Clinact","has_results":false},{"nct_id":"NCT03564119","title":"A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"Sol-Gel Technologies, Ltd.","has_results":true},{"nct_id":"NCT03448939","title":"A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":361,"lead_sponsor_name":"Sol-Gel Technologies, Ltd.","has_results":true},{"nct_id":"NCT05343455","title":"A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"Journey Medical Corporation","has_results":true},{"nct_id":"NCT05296629","title":"A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Journey Medical Corporation","has_results":true},{"nct_id":"NCT02787616","title":"Genetic Basis of Rosacea","phase":"","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT03075891","title":"Oracea Soolantra Association in Participants With Severe Rosacea","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":273,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT03263273","title":"Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Hovione Scientia Limited","has_results":false},{"nct_id":"NCT05150587","title":"Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Alfasigma S.p.A.","has_results":true},{"nct_id":"NCT07046039","title":"The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.","phase":"","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"King Abdulaziz University","has_results":false},{"nct_id":"NCT04472546","title":"Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Pierre Fabre Dermo Cosmetique","has_results":false},{"nct_id":"NCT03667222","title":"Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":207,"lead_sponsor_name":"BioPharmX, Inc.","has_results":false},{"nct_id":"NCT02602470","title":"Preferences & Treatment Satisfaction Drivers in Rosacea Patients","phase":"","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"LEO Pharma","has_results":false},{"nct_id":"NCT03340961","title":"A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":205,"lead_sponsor_name":"Dr. Reddy's Laboratories Limited","has_results":true},{"nct_id":"NCT07343635","title":"The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea","phase":"NA","overall_status":"RECRUITING","enrollment_count":186,"lead_sponsor_name":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT06271135","title":"Assessing the Quality of Life of Patients With Rosacea","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Medical University of Bialystok","has_results":false},{"nct_id":"NCT07443202","title":"Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":155,"lead_sponsor_name":"Tarsus Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03228927","title":"Characterization of the Facial and Gut Microbiome in Rosacea","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"The Acne Cure Alliance","has_results":false},{"nct_id":"NCT05942248","title":"The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Integrative Skin Science and Research","has_results":false},{"nct_id":"NCT03590366","title":"A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"AOBiome LLC","has_results":true},{"nct_id":"NCT04377841","title":"Facial Demodicosis and Ocular Demodicosis","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07296497","title":"Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety","phase":"NA","overall_status":"RECRUITING","enrollment_count":104,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT03479853","title":"Clinical, Meibographic and Interferometric Evaluation of Phlyctenular Keratitis in Children - MEIBO-ROSACEE","phase":"","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT04555525","title":"A Pilot Study on the Use of Seysara for Rosacea","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Derm Research, PLLC","has_results":true},{"nct_id":"NCT01885000","title":"Patient-Reported Outcome Of Facial Erythema (PROOF)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT05094700","title":"A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants","phase":"NA","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Johnson & Johnson Consumer Inc. (J&JCI)","has_results":false},{"nct_id":"NCT07410533","title":"Analysis of Factors Associated With the Efficacy of 595-nm Pulsed Dye Laser Treatment for Rosacea","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03392558","title":"The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Burt's Bees Inc.","has_results":false},{"nct_id":"NCT04886739","title":"CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"CAGE Bio Inc.","has_results":false},{"nct_id":"NCT07106957","title":"Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin","phase":"NA","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"Beijing Sino-German Union Cosmetic Institute Co., Ltd.","has_results":false},{"nct_id":"NCT06582043","title":"Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"NAOS Argentina S.A.","has_results":false},{"nct_id":"NCT05815511","title":"Clinical Trial to Evaluate the Effect of a Probiotic Mixture on the Rosacea Evolution","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Bionou Research, S.L.","has_results":false},{"nct_id":"NCT05597462","title":"Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Journey Medical Corporation","has_results":false},{"nct_id":"NCT04336163","title":"Skin Imaging to Inform Laser Treatments","phase":"NA","overall_status":"TERMINATED","enrollment_count":55,"lead_sponsor_name":"University of California, Irvine","has_results":true},{"nct_id":"NCT06776445","title":"Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT07521462","title":"Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"ISISPHARMA","has_results":false},{"nct_id":"NCT05296837","title":"Ocular Rosacea Biome Study","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03352323","title":"An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Padagis LLC","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}